scispace - formally typeset
F

Fumio Tashiro

Researcher at Tokyo University of Science

Publications -  61
Citations -  1600

Fumio Tashiro is an academic researcher from Tokyo University of Science. The author has contributed to research in topics: Phosphorylation & Cellular differentiation. The author has an hindex of 22, co-authored 61 publications receiving 1459 citations.

Papers
More filters
Journal ArticleDOI

PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of Akt

TL;DR: PHLDA3 is identified as a p53 target gene that encodes a PH domain-only protein that competes with the PH domain of Akt for binding of membrane lipids, thereby inhibiting Akt translocation to the cellular membrane and activation.
Journal ArticleDOI

α-Zearalenol, a Major Hepatic Metabolite in Rats of Zearalenone, an Estrogenic Mycotoxin of Fusarium Species

TL;DR: All the chemical and physical data supported the view that the major metabolite, obtained by incubating zearalenone with S-9 and microsomes of rat liver in the presence of NADPH, is C-6'-alpha-hydroxylated zearAlenone (alpha-zear alenol).
Journal ArticleDOI

p53 target gene AEN is a nuclear exonuclease required for p53-dependent apoptosis

TL;DR: It is reported that apoptosis-enhancing nuclease (AEN) is a novel direct target gene of p53, and its expression is regulated by the phosphorylation status of p 53, and it is shown to be required for efficient DNA fragmentation in p53-dependent apoptosis.
Journal ArticleDOI

Physical and functional interaction between BH3-only protein Hrk and mitochondrial pore-forming protein p32.

TL;DR: Yeast two-hybrid screening for Hrk-interacting proteins and isolated p32 suggest that p32 may be a key molecule that links HRk to mitochondria and is critically involved in the regulation of HrK-mediated apoptosis.
Journal ArticleDOI

A Novel Binding Factor of 14-3-3β Functions as a Transcriptional Repressor and Promotes Anchorage-independent Growth, Tumorigenicity, and Metastasis

TL;DR: Results indicate that FBI1 promotes sustained ERK1/2 activation through repression of MKP-1 transcription, resulting in promotion of tumorigenicity and metastasis.